Sarah Whelan, PhD
Science Writer
at Technology Networks
Sarah joined Technology Networks in 2022 after completing a PhD in cancer biology, where her research focused on the development of colon cancers. In her role as science writer and editor, Sarah covers scientific news and a range of other content types, leading the site's coverage of drug discovery, biopharma and cancer research content.
Education
Areas of Expertise
Got a Question for Sarah Whelan, PhD?
Get in touch using the contact form linked here and we’ll get back to you shortly.
Published Content
Total: 304
Industry Insight
Semarion Wins SLAS Europe Ignite Award 2024
At SLAS Europe 2024, Technology Networks had the pleasure of speaking with Jeroen Verheyen, CEO of Semarion, to discuss their award-winning work and how technological innovations advance research.
News
Antidiabetic Drug Tirzepatide Could Benefit Sleep Apnea Patients
A new clinical trial suggests that an antidiabetic drug, tirzepatide, could effectively treat obstructive sleep apnea (OSA). These data could pave the way to improved quality of life for people affected by the sleep-related disorder.
Industry Insight
SLAS Europe 2024 New Product Award Winners
Two winners earned the New Product Award at SLAS Europe 2024: SEED Biosciences’ Dispen3D and Cryologyx’s PlateReady™. Technology Networks spoke with CEO of CryoLogyx Tom Congdon to learn more about their award-winning new product.
Industry Insight
What FDA Approval of MDMA Could Mean for the Future of Psychedelic Therapy
To learn more about the FDA's pending decision on MDMA-assisted therapy for PTSD, Technology Networks interviewed Dr. Sam Clark, CEO of Terran Biosciences, who leads one of the industry’s largest psychedelic development programs.
Industry Insight
Tackling Plastic Waste for More Sustainable Science
At SLAS Europe 2024, Technology Networks had the pleasure of speaking with Tim Dillon, market manager (Nordics) at Mettler-Toledo Rainin, to learn about how more sustainable options can be implemented into scientists’ daily workflows.
News
Algae-Based Microbots Deliver Cancer Drugs Directly to Lung Tumors
Combining biology and nanotechnology, researchers have developed algae-based “microbots” to deliver drugs directly to lung tumors in mice – with the approach showing promise for reducing tumor growth and increasing survival.
News
Glowing Dye May Help Surgeons Cut Out Prostate Cancer
A fluorescent dye may provide surgeons with a “second pair of eyes” in surgery, helping to remove prostate cancer tumors without damaging healthy tissue.
News
“Artificial Lymph Node” May Help Train the Immune System To Kill Cancer Cells
A new study has found that implanting an “artificial lymph node” under the skin of mice may act as a hub to teach immune cells how to recognize and kill cancer cells, prolonging mouse survival and slowing tumor growth.
News
First Patient Dosed in Study To Unravel “Mystical Experiences” of Psychedelic Derived From Toad Skin
The first participant in a new psychedelic study has received a dose of a synthetic formulation of 5-MeO-DMT. The study is set to evaluate its neurophysiological effects on the human brain and perceived “mystical experiences.”
News
“Message in a Bottle” Cancer Therapy Shows Promise in Mice
Researchers have used small membrane bubbles – which our cells use to communicate – to deliver targeted cancer treatments to tumors in mouse models, demonstrating reduced tumor growth and extended survival in one model.
Advertisement
